Therefore, the present study aimed to construct models to predict the HER2 status of breast cancer by utilizing model weighted combination and feature combination methods based on ABVS intratumoral and peritumoral imaging features and clinically relevant features, to obtain the optimal model and provide the best basis for clinical decision-making for breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.